Inventor
BUCKL ANDREAS
US14 patents
Patents
14 patentsUS10590090B2Mar 17, 2020
2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC28 citations92
US11566007B2Jan 31, 2023
Ras inhibitors
REVOLUTION MEDICINES INC10 citations85
US11739074B2Aug 29, 2023
Ras inhibitors
REVOLUTION MEDICINES INC9 citations84
US11690915B2Jul 4, 2023
Ras inhibitors
REVOLUTION MEDICINES INC9 citations82
US12202845B2Jan 21, 2025
Ras inhibitors
REVOLUTION MEDICINES INC3 citations74
US11168102B1Nov 9, 2021
Bicyclic heteroaryl compounds and uses thereof
REVOLUTION MEDICINES INC5 citations70
US11673896B2Jun 13, 2023
Pyridine compounds as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC1 citations61
US12565476B2Mar 3, 2026
2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC0 citations60
US11702411B2Jul 18, 2023
Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC0 citations60
US11661401B2May 30, 2023
2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC0 citations60
US12365688B2Jul 22, 2025
Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC0 citations59
US12258366B2Mar 25, 2025
Bicyclic heteroaryl compounds and uses thereof
REVOLUTION MEDICINES INC0 citations59
US11739093B2Aug 29, 2023
Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC1 citations59
US11673901B2Jun 13, 2023
Polycyclic compounds as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC0 citations47